Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Mary Marcus appointed CEO of NewAge Industries

By Brian Buntz | December 19, 2024

NewAge IndustriesPress release: Southampton, PA – NewAge Industries, Inc., parent company of AdvantaPure™ and NewAge Performance Products, a global leader in fluid transfer systems solutions for the biopharma and industrial markets, is pleased to announce the appointment of Mary Marcus to the position of CEO. “Since her arrival in 2008, Mary has been a vital part of NewAge Industries. In her most recent role as Interim CEO & General Manager, Mary has successfully led the organization while strategically positioning it as a global leader with tremendous growth opportunity within the industry,” said Andreas Georghiou, Lead Director of the Board.

“I enthusiastically support Mary’s appointment to CEO. I have been impressed by her commitment and dedication to the Company, its team members and to our many global partners,” said Ken Baker, previous CEO and current member of the NewAge Industries, Inc. Board of Directors.

Mary joined NewAge in 2008, in Supply Chain Operations. She subsequently held numerous leadership roles in operational functions which have enabled the Company to successfully navigate the incredible growth and challenges that come with servicing the BioPharma industry, including the establishment and development of Single Use Sterilization programs, the build-out of several cleanroom production suites, the Quality Management System and the expansion of the Company’s global footprint with the launch of a new manufacturing site in Europe earlier this year.

Mary graduated from Penn State University with a Bachelor’s Degree in Business Administration and attained her Master of Science in Organizational Development from St. Joseph’s University. “Ken has done an amazing job setting the company up for success and created such a strong foundation upon which to build. I am honored and humbled to be able to lead the organization into the next chapter,” said Ms. Marcus.

About NewAge Industries, Inc.: In business since 1954, NewAge Industries, Inc. the parent company of AdvantaPure and NewAge Performance Products, designs, manufactures, and distributes fluid transfer systems solutions, of a variety of materials, including silicone, TPE, rubber and more, in reinforced and unreinforced styles, for the high purity pharmaceutical, biopharma and industrial markets. An ISO-9001 certified, 100% employee-owned corporation (ESOP) that has earned a Gold Ecovadis Sustainability Rating and is also a Certified B Corporation®. NewAge Industries, Inc. administers the activities of their AdvantaPure, AdvantaFlex™, AdvantaSil™, and BioClosure™ container closure systems, and other lines from their corporate headquarters in Southampton, PA, U.S. location in Warrington, PA, and Coevorden, Netherlands location.


Filed Under: Drug Discovery and Development

 

About The Author

Brian Buntz

As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology. While he has long maintained a keen interest in AI, more recently Brian has made making data analysis a central focus, and is exploring tools ranging from NLP and clustering to predictive analytics.

Throughout his 18-year tenure, Brian has covered an array of life science topics, including clinical trials, medical devices, and drug discovery and development. Prior to WTWH, he held the title of content director at Informa, where he focused on topics such as connected devices, cybersecurity, AI and Industry 4.0. A dedicated decade at UBM saw Brian providing in-depth coverage of the medical device sector. Engage with Brian on LinkedIn or drop him an email at [email protected].

Related Articles Read More >

Sai Life Sciences to double process R&D capacity with new Hyderabad facility
How stereo-correct data can de-risk AI-driven drug discovery
Pfizer stock jumps 14% as TrumpRx drug pricing deal eases tariff fears
See it in 1 second, act in 60: Eschbach’s take on how visual factories enable measurable decisions
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE